These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 16724981)
1. Hepatitis B core antigen expression pattern reflects the response to anti-viral treatment. Uzun Y; Bozkaya H; Erden E; Cinar K; Idilman R; Yurdaydin C; Uzunalimoglu O J Gastroenterol Hepatol; 2006 Jun; 21(6):977-81. PubMed ID: 16724981 [TBL] [Abstract][Full Text] [Related]
2. [Hepatitis B core antigen expression pattern predicts response to lamivudine therapy in patients with chronic hepatitis B]. Shi KD; Hwang SG; Choi JH; Hwang IJ; Yoon JH; Kim KI; Kwon CI; Hong SP; Park PW; Rim KS Korean J Hepatol; 2008 Jun; 14(2):197-205. PubMed ID: 18617767 [TBL] [Abstract][Full Text] [Related]
3. Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients. Tang TJ; de Man RA; Kusters JG; Kwekkeboom J; Hop WC; van der Molen RG; Schalm SW; Janssen HL J Med Virol; 2004 Feb; 72(2):215-22. PubMed ID: 14695662 [TBL] [Abstract][Full Text] [Related]
4. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study. Ramakrishna B; Mukhopadhya A; Kurian G J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848 [TBL] [Abstract][Full Text] [Related]
6. Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients. Wang CC; Liu CJ; Lai MY; Kao JH; Chen DS Liver Int; 2007 Mar; 27(2):235-9. PubMed ID: 17311619 [TBL] [Abstract][Full Text] [Related]
7. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients. Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Kao JH; Chen DS Liver Int; 2008 Aug; 28(7):1034-41. PubMed ID: 18492018 [TBL] [Abstract][Full Text] [Related]
8. Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection. Fischler B; Nyström J; Björnsdottir T; Lindh G; Hultgren C J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):75-83. PubMed ID: 17592368 [TBL] [Abstract][Full Text] [Related]
9. Correlation of hepatitis B core antigen and beta-catenin expression on hepatocytes in chronic hepatitis B virus infection: relevance to the severity of liver damage and viral replication. Kim CW; Yoon SK; Jung ES; Jung CK; Jang JW; Kim MS; Lee SY; Bae SH; Choi JY; Choi SW; Han NI; Lee CD J Gastroenterol Hepatol; 2007 Sep; 22(9):1534-42. PubMed ID: 17559383 [TBL] [Abstract][Full Text] [Related]
10. P21 expression and its relation to disease activity and hepatocyte proliferation in chronic hepatitis B virus infection. Varli M; Heper AO; Erden E; Uzunalimoğlu O; Yurdaydin C; Bozkaya H Turk J Gastroenterol; 2005 Mar; 16(1):12-6. PubMed ID: 16252182 [TBL] [Abstract][Full Text] [Related]
11. [Relationship between core gene mutations of hepatitis B virus and response to alpha interferon therapy in chronic hepatitis B]. Yoo BC; Kim HJ; Do JH; Park SM Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):381-8. PubMed ID: 12506242 [TBL] [Abstract][Full Text] [Related]
12. Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial. Chan HL; Wang H; Niu J; Chim AM; Sung JJ Antivir Ther; 2007; 12(3):345-53. PubMed ID: 17591024 [TBL] [Abstract][Full Text] [Related]
13. Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels. Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Chen DS; Kao JH Antivir Ther; 2009; 14(2):203-10. PubMed ID: 19430095 [TBL] [Abstract][Full Text] [Related]
14. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up]. Liu DL; Luo KX; Feng XR; Fu QX; Hou JL Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996 [TBL] [Abstract][Full Text] [Related]
15. Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. Gish RG; Lok AS; Chang TT; de Man RA; Gadano A; Sollano J; Han KH; Chao YC; Lee SD; Harris M; Yang J; Colonno R; Brett-Smith H Gastroenterology; 2007 Nov; 133(5):1437-44. PubMed ID: 17983800 [TBL] [Abstract][Full Text] [Related]
16. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion. Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999 [TBL] [Abstract][Full Text] [Related]
17. Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment. Sarin SK; Kumar M; Hissar S; Sharma BC Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):374-80. PubMed ID: 16911934 [TBL] [Abstract][Full Text] [Related]
18. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment]. Veldhuijzen IK; Mostert MC; Niesters HG; Richardus JH; de Man RA Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1426-30. PubMed ID: 18624006 [TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B. Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536 [TBL] [Abstract][Full Text] [Related]
20. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy. Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]